Controlled release dosage form
US11090281B2 · kind B2 · utility
0Cited by
23References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 24, 2020 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | Feb 24, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.